文献速递心脑血管急症重症综合管理与镇静镇痛

神经反馈训练对缺血缺氧性脑病患者床旁连续脑电图相对α变异评分及超声视神经鞘直径的影响

[Effect of neurofeedback training on relative α variant score monitored by bedside continuous electroencephalography and optic nerve sheath diameter evaluated by ultrasound in patients with ischemic hypoxic encephalopathy].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论在缺血缺氧性脑病(GCS≤8)患者中,加用14天神经反馈训练可改善脑电图功率、HAMD、NIHSS、5-HT、BDNF及NLR,但研究为观察性设计。

本研究为前瞻性观察性研究,纳入上海市浦东新区人民医院急诊与重症医学科2021年1月至2023年12月收治的缺血缺氧性脑病且入院GCS≤8患者,神经反馈训练组60例、未训练对照组50例;两组均接受神经节苷脂联合脑蛋白水解物静脉神经营养治疗10天为一疗程,观察组另加视觉反馈、听觉反馈、冥想放松等连续神经反馈训练14天。结果显示观察组ONDS及相对α变异评分显著高于对照组(均P<0.01);训练14天后观察组5个脑电通道平均功率及DTR较治疗前显著降低(均P<0.05),对照组治疗前后平均功率无显著差异;治疗14天后观察组HAMD、NIHSS、5-HT、BDNF、NLR均优于对照组(均P<0.01)。作者认为神经反馈训练可有效改善缺血缺氧性脑病患者的脑功能。

要点

  • 观察组ONDS 5.59±0.42 mm、相对α变异评分2.28±0.39,均显著高于对照组3.23±0.34 mm、0.83±0.28(均P<0.01)。
  • 神经反馈训练14天后观察组5个脑电通道平均功率均较治疗前显著降低(均P<0.05),对照组治疗前后平均功率无显著差异。
  • 治疗14天后观察组HAMD 4.59±1.06、NIHSS 6.81±0.66,均显著低于对照组10.69±0.97、8.45±0.87(均P<0.01)。
  • 治疗14天后观察组5-HT 150.25±17.37 mg/L、BDNF 19.37±2.35 mg/L高于对照组123.34±16.18 mg/L、12.48±2.18 mg/L,NLR 4.78±0.83低于对照组5.81±1.17(均P<0.01)。

适用人群与场景

  • 上海市浦东新区人民医院急诊与重症医学科2021年1月至2023年12月收治的缺血缺氧性脑病患者,入院GCS≤8,接受神经反馈训练者纳入观察组(60例)。
  • 同期未接受神经反馈训练且入院GCS≤8的缺血缺氧性脑病患者纳入对照组(50例)。

诊断标准与关键阈值

  • 缺血缺氧性脑病诊断标准,入院时GCS≤8。
  • 相对α变异评分由床旁连续脑电图监测获得,ONDS由超声测定。

处置流程与药物剂量

  • 两组均接受神经节苷脂联合脑蛋白水解物静脉神经营养治疗,10天为一疗程。
  • 观察组在此基础上另接受连续神经反馈训练,包括视觉反馈、听觉反馈、冥想放松,共14天。
  • 床旁连续脑电图监测相对α变异评分,超声测定ONDS;检测5个脑电通道平均功率及慢波功率(以δ-θ比值DTR表示)。

研究设计与关键结果

  • 前瞻性观察性研究,观察组60例、对照组50例;两组性别、年龄、病程无显著差异。
  • 观察组ONDS 5.59±0.42 mm、相对α变异评分2.28±0.39,均显著高于对照组3.23±0.34 mm、0.83±0.28(均P<0.01)。
  • 神经反馈训练14天后观察组5个脑电通道平均功率较治疗前显著降低:Fp1 95.35±3.61 vs. 102.58±4.23 μV²/Hz、F3 38.56±4.73 vs. 46.13±2.36 μV²/Hz、C3 34.33±5.87 vs. 51.71±4.65 μV²/Hz、F7 58.37±4.45 vs. 62.95±3.22 μV²/Hz、T3 45.23±2.41 vs. 54.14±2.45 μV²/Hz(均P<0.05)。
  • 神经反馈训练14天后观察组DTR较治疗前显著降低:GND 75.21±11.34 vs. 84.12±11.35 μV²/Hz、REF 72.31±21.67 vs. 88.23±10.25 μV²/Hz、F4 81.34±8.57 vs. 92.41±8.56 μV²/Hz、P3 71.25±5.42 vs. 87.23±5.64 μV²/Hz、P4 70.12±5.88 vs. 85.67±6.12 μV²/Hz(均P<0.05)。
  • 对照组治疗前后5个脑电通道平均功率无显著差异。
  • 两组治疗前HAMD、NIHSS无显著差异;治疗14天后均较治疗前显著降低,且观察组降低更明显(HAMD 4.59±1.06 vs. 10.69±0.97,NIHSS 6.81±0.66 vs. 8.45±0.87,均P<0.01)。
  • 两组治疗前血浆5-HT、BDNF及外周血NLR无显著差异;治疗14天后均较治疗前改善,观察组优于对照组:5-HT 150.25±17.37 vs. 123.34±16.18 mg/L、BDNF 19.37±2.35 vs. 12.48±2.18 mg/L、NLR 4.78±0.83 vs. 5.81±1.17(均P<0.01)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为神经反馈训练可有效改善缺血缺氧性脑病患者的脑功能。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To approach the evaluation of relative α variant score monitored by bedside continuous electroencephalography and optic nerve sheath diameter (ONSD) evaluated by ultrasound in patients with ischemic hypoxic encephalopathy, and to observe the effect of neurofeedback training on brain function.

METHODS: A prospective observational study was conducted. The patients admitted to the emergency and intensive care department of Shanghai Pudong New Area People's Hospital from January 2021 to December 2023, who meet the diagnostic criteria of ischemic hypoxic encephalopathy with the Glasgow coma score (GCS) ≤ 8 at admission receiving neurofeedback training were enrolled as the study object (observation group), and the patients without neurofeedback training and GCS score ≤ 8 at admission were enrolled as the controls (control group). Both groups received intravenous neurotrophic therapy combining ganglioside and cerebrolysin for 10 days as one course of treatment. On this basis, the observation group additionally received continuous neurofeedback training including visual feedback, auditory feedback, meditation and relaxation for 14 days. Bedside continuous electroencephalography was used for monitoring relative α variation score, and ultrasound was used to determine ONSD. The average power and slow wave power [expressed as delta-theta ratio (DTR)] of five channels in electroencephalography before and 14 days after neurofeedback training were examined. The differences in peripheral blood neutrophil/lymphocyte ratio (NLR), Hamilton depression scale (HAMD) score, National Institutes of Health stroke scale (NIHSS) score, plasma levels of 5-hydroxytryptamine (5-HT) and brain-derived neurotrophic factor (BDNF).

RESULTS: A total of 60 patients were enrolled in the observation group and 50 patients in the control group finally. There was no significant difference in gender, age or course of disease between the two groups. The ONSD and relative α variant score in the observation group were significantly higher than those in the control group [ONDS (mm): 5.59±0.42 vs. 3.23±0.34, relative α variant score: 2.28±0.39 vs. 0.83±0.28, both P < 0.01]. After neurofeedback training for 14 days, the mean power and DTR in five channels of electroencephalography in the observation group were significantly lower than those before treatment [mean power (μV2/Hz): 95.35±3.61 vs. 102.58±4.23 in frontal pole 1 (Fp1), 38.56±4.73 vs. 46.13±2.36 in frontal 3 (F3), 34.33±5.87 vs. 51.71±4.65 in central 3 (C3), 58.37±4.45 vs. 62.95±3.22 in F7, 45.23±2.41 vs. 54.14±2.45 in temporal 3 (T3); DTR (μV2/Hz): 75.21±11.34 vs. 84.12±11.35 in ground electrode (GND), 72.31±21.67 vs. 88.23±10.25 in reference electrode (REF), 81.34±8.57 vs. 92.41±8.56 in F4, 71.25±5.42 vs. 87.23±5.64 in parietal 3 (P3), 70.12±5.88 vs. 85.67±6.12 in P4; all P < 0.05]. However, there was no significant difference in the mean power of five channels before and after treatment in the control group. There was no significant difference in the HAMD score or NIHSS score before treatment between the two groups. The above scores at 14 days after treatment were significantly lower than before, and the decrease was more significant in the observation group (HAMD score: 4.59±1.06 vs. 10.69±0.97, NIHSS score: 6.81±0.66 vs. 8.45±0.87, both P < 0.01). There was no significant difference in the plasma 5-HT, BDNF or peripheral blood NLR before treatment between the two groups. The above parameters at 14 days after treatment were improved as compared with before, and the levels in the observation group were superior to control group [5-HT (mg/L): 150.25±17.37 vs. 123.34±16.18, BDNF (mg/L): 19.37±2.35 vs. 12.48±2.18, NLR: 4.78±0.83 vs. 5.81±1.17, all P < 0.01].

CONCLUSIONS: Both ONDS determined by ultrasound and relative α variation score monitored by electroencephalography changed significantly in the patients with ischemic hypoxic encephalopathy. Neurofeedback training can effectively improve brain function in patients with ischemic hypoxic encephalopathy.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Sun J, Wan J. [Effect of neurofeedback training on relative α variant score monitored by bedside continuous electroencephalography and optic nerve sheath diameter evaluated by ultrasound in patients with ischemic hypoxic encephalopathy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 39968589. doi:10.3760/cma.j.cn121430-20240509-00421

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。